HSBC keeps HKD 15.45 target for China Medical System stock

Published on 10/20/2026 at 20:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The next results are due on March 16, 2027 after first-half results. China Medical System stock costs EUR 1.18 on October 20, 2026 at 8:37 p.m. CEST.

Analyst target and reporting date

HSBC kept its HKD 15.45 target for China Medical System on September 29, 2026.
Revenue reached CNY 4.50 billion in the first half of 2026.
China Medical System stock costs EUR 1.18 at Lang & Schwarz on October 20, 2026 at 8:37 p.m. CEST.
The next results are scheduled for March 16, 2027.

CMS, KYG211081248, Illustration mit AI erstellt.

China Medical System (KYG211081248) remains linked to HSBC's HKD 15.45 target, which the bank kept on September 29, 2026, according to Investing.com. The target lies 48.84 percent above the HKD 10.38 Hong Kong close on October 20, 2026. At Lang & Schwarz, the stock was trading at EUR 1.18 on October 20, 2026 at 8:37 p.m. CEST.

Target stays at HKD 15.45

HSBC's unchanged target gives investors a dated valuation reference in the Hong Kong currency. The target is also below the reported 52-week high of HKD 15.52, leaving only HKD 0.07 between the two levels.

The Hong Kong listing closed at HKD 10.38 on October 20, 2026, while the 52-week range stood at HKD 9.51 to HKD 15.52. The market capitalization was HKD 25.3 billion, and volume reached 4,891,000 shares on the same session.

First-half revenue reached CNY 4.50 billion

China Medical System reported revenue of CNY 4.50 billion for the first half of 2026, with earnings per share of CNY 0.41, according to Investing.com. The reporting period ended in June 2026 and was published on August 17, 2026. The company operates in specialty and generic drug manufacturing, with products marketed across China.

Results date points to March 16

The next earnings report is scheduled for March 16, 2027, according to TradingView. That date gives the market its next fixed checkpoint after the first-half figures.

Euro quote remains the German reference

The euro quotation places the Hong Kong pharmaceutical group at EUR 1.18 for German investors, while the home-market value remains HKD 10.38. The two prices use different currencies and are not combined into one performance figure.

China Medical System was trading at EUR 1.18 at Lang & Schwarz on October 20, 2026 at 8:37 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of China Medical System stock.